-
1
-
-
8844266996
-
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
-
Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44: 595-600.
-
(2004)
Neuron
, vol.44
, pp. 595-600
-
-
Paisan-Ruiz, C.1
Jain, S.2
Evans, E.W.3
Gilks, W.P.4
Simon, J.5
-
2
-
-
8844233579
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
-
Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44: 601-607.
-
(2004)
Neuron
, vol.44
, pp. 601-607
-
-
Zimprich, A.1
Biskup, S.2
Leitner, P.3
Lichtner, P.4
Farrer, M.5
-
3
-
-
34548621385
-
Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants
-
Li X, Tan YC, Poulose S, Olanow CW, Huang XY, et al. (2007) Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants. J Neurochem 103: 238-247.
-
(2007)
J Neurochem
, vol.103
, pp. 238-247
-
-
Li, X.1
Tan, Y.C.2
Poulose, S.3
Olanow, C.W.4
Huang, X.Y.5
-
4
-
-
28044460070
-
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
-
West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, et al. (2005) Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102: 16842-16847.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 16842-16847
-
-
West, A.B.1
Moore, D.J.2
Biskup, S.3
Bugayenko, A.4
Smith, W.W.5
-
5
-
-
33748993710
-
Kinase activity of mutant LRRK2 mediates neuronal toxicity
-
Smith WW, Pei Z, Jiang H, Dawson VL, Dawson TM, et al. (2006) Kinase activity of mutant LRRK2 mediates neuronal toxicity. Nat Neurosci 9: 1231-1233.
-
(2006)
Nat Neurosci
, vol.9
, pp. 1231-1233
-
-
Smith, W.W.1
Pei, Z.2
Jiang, H.3
Dawson, V.L.4
Dawson, T.M.5
-
6
-
-
34548604567
-
The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity
-
Guo L, Gandhi PN, Wang W, Petersen RB, Wilson-Delfosse AL, et al. (2007) The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity. Exp Cell Res 313: 3658-3670.
-
(2007)
Exp Cell Res
, vol.313
, pp. 3658-3670
-
-
Guo, L.1
Gandhi, P.N.2
Wang, W.3
Petersen, R.B.4
Wilson-Delfosse, A.L.5
-
7
-
-
33746267531
-
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
-
Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, et al. (2006) Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Neurobiol Dis 23: 329-341.
-
(2006)
Neurobiol Dis
, vol.23
, pp. 329-341
-
-
Greggio, E.1
Jain, S.2
Kingsbury, A.3
Bandopadhyay, R.4
Lewis, P.5
-
8
-
-
33751256567
-
The familial Parkinsonism gene LRRK2 regulates neurite process morphology
-
MacLeod D, Dowman J, Hammond R, Leete T, Inoue K, et al. (2006) The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 52: 587-593.
-
(2006)
Neuron
, vol.52
, pp. 587-593
-
-
MacLeod, D.1
Dowman, J.2
Hammond, R.3
Leete, T.4
Inoue, K.5
-
9
-
-
47749114984
-
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
-
Greggio E, Zambrano I, Kaganovich A, Beilina A, Taymans JM, et al. (2008) The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J Biol Chem 283: 16906-16914.
-
(2008)
J Biol Chem
, vol.283
, pp. 16906-16914
-
-
Greggio, E.1
Zambrano, I.2
Kaganovich, A.3
Beilina, A.4
Taymans, J.M.5
-
10
-
-
40349101849
-
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
-
Deng J, Lewis PA, Greggio E, Sluch E, Beilina A, et al. (2008) Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A 105: 1499-1504.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 1499-1504
-
-
Deng, J.1
Lewis, P.A.2
Greggio, E.3
Sluch, E.4
Beilina, A.5
-
11
-
-
73649120624
-
Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization
-
Sen S, Webber PJ, West AB, (2009) Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. J Biol Chem 284: 36346-36356.
-
(2009)
J Biol Chem
, vol.284
, pp. 36346-36356
-
-
Sen, S.1
Webber, P.J.2
West, A.B.3
-
12
-
-
77956441086
-
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
-
Lee BD, Shin JH, VanKampen J, Petrucelli L, West AB, et al. Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease. Nat Med 16: 998-1000.
-
Nat Med
, vol.16
, pp. 998-1000
-
-
Lee, B.D.1
Shin, J.H.2
VanKampen, J.3
Petrucelli, L.4
West, A.B.5
-
13
-
-
70449377127
-
Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis
-
Parisiadou L, Xie C, Cho HJ, Lin X, Gu XL, et al. (2009) Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J Neurosci 29: 13971-13980.
-
(2009)
J Neurosci
, vol.29
, pp. 13971-13980
-
-
Parisiadou, L.1
Xie, C.2
Cho, H.J.3
Lin, X.4
Gu, X.L.5
-
14
-
-
39549117093
-
Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells
-
Plowey ED, Cherra SJ 3rd, Liu YJ, Chu CT, (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105: 1048-1056.
-
(2008)
J Neurochem
, vol.105
, pp. 1048-1056
-
-
Plowey, E.D.1
Cherra 3rd, S.J.2
Liu, Y.J.3
Chu, C.T.4
-
15
-
-
0034117078
-
14-3-3 proteins: structure, function, and regulation
-
Fu H, Subramanian RR, Masters SC, (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647.
-
(2000)
Annu Rev Pharmacol Toxicol
, vol.40
, pp. 617-647
-
-
Fu, H.1
Subramanian, R.R.2
Masters, S.C.3
-
16
-
-
0031470652
-
The structural basis for 14-3-3:phosphopeptide binding specificity
-
Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, et al. (1997) The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91: 961-971.
-
(1997)
Cell
, vol.91
, pp. 961-971
-
-
Yaffe, M.B.1
Rittinger, K.2
Volinia, S.3
Caron, P.R.4
Aitken, A.5
-
17
-
-
0032568944
-
Mutations in the hydrophobic surface of an amphipathic groove of 14-3-3zeta disrupt its interaction with Raf-1 kinase
-
Wang H, Zhang L, Liddington R, Fu H, (1998) Mutations in the hydrophobic surface of an amphipathic groove of 14-3-3zeta disrupt its interaction with Raf-1 kinase. J Biol Chem 273: 16297-16304.
-
(1998)
J Biol Chem
, vol.273
, pp. 16297-16304
-
-
Wang, H.1
Zhang, L.2
Liddington, R.3
Fu, H.4
-
18
-
-
33645293151
-
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation
-
Jin Y, Dai MS, Lu SZ, Xu Y, Luo Z, et al. (2006) 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 25: 1207-1218.
-
(2006)
EMBO J
, vol.25
, pp. 1207-1218
-
-
Jin, Y.1
Dai, M.S.2
Lu, S.Z.3
Xu, Y.4
Luo, Z.5
-
19
-
-
25144441037
-
Role of 14-3-3 proteins in eukaryotic signaling and development
-
Darling DL, Yingling J, Wynshaw-Boris A, (2005) Role of 14-3-3 proteins in eukaryotic signaling and development. Curr Top Dev Biol 68: 281-315.
-
(2005)
Curr Top Dev Biol
, vol.68
, pp. 281-315
-
-
Darling, D.L.1
Yingling, J.2
Wynshaw-Boris, A.3
-
20
-
-
0029166558
-
Bcr and Raf form a complex in vivo via 14-3-3 proteins
-
Braselmann S, McCormick F, (1995) Bcr and Raf form a complex in vivo via 14-3-3 proteins. EMBO J 14: 4839-4848.
-
(1995)
EMBO J
, vol.14
, pp. 4839-4848
-
-
Braselmann, S.1
McCormick, F.2
-
21
-
-
76149134717
-
Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S
-
Li X, Patel JC, Wang J, Avshalumov MV, Nicholson C, et al. (2019S) Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S. J Neurosci 30: 1788-1797.
-
(2019)
J Neurosci
, vol.30
, pp. 1788-1797
-
-
Li, X.1
Patel, J.C.2
Wang, J.3
Avshalumov, M.V.4
Nicholson, C.5
-
22
-
-
33846818834
-
GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease
-
Ito G, Okai T, Fujino G, Takeda K, Ichijo H, et al. (2007) GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 46: 1380-1388.
-
(2007)
Biochemistry
, vol.46
, pp. 1380-1388
-
-
Ito, G.1
Okai, T.2
Fujino, G.3
Takeda, K.4
Ichijo, H.5
-
23
-
-
0030613761
-
Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A
-
Daaka Y, Luttrell LM, Lefkowitz RJ, (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91.
-
(1997)
Nature
, vol.390
, pp. 88-91
-
-
Daaka, Y.1
Luttrell, L.M.2
Lefkowitz, R.J.3
-
24
-
-
77956674229
-
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
-
Nichols RJ, Dzamko N, Morrice NA, Campbell DG, Deak M, et al. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization. Biochem J 430: 393-404.
-
Biochem J
, vol.430
, pp. 393-404
-
-
Nichols, R.J.1
Dzamko, N.2
Morrice, N.A.3
Campbell, D.G.4
Deak, M.5
-
25
-
-
77956655427
-
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization
-
Dzamko N, Deak M, Hentati F, Reith AD, Prescott AR, et al. Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser(910)/Ser(935), disruption of 14-3-3 binding and altered cytoplasmic localization. Biochem J 430: 405-413.
-
Biochem J
, vol.430
, pp. 405-413
-
-
Dzamko, N.1
Deak, M.2
Hentati, F.3
Reith, A.D.4
Prescott, A.R.5
-
26
-
-
0030887128
-
Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein
-
Wakui H, Wright AP, Gustafsson J, Zilliacus J, (1997) Interaction of the ligand-activated glucocorticoid receptor with the 14-3-3 eta protein. J Biol Chem 272: 8153-8156.
-
(1997)
J Biol Chem
, vol.272
, pp. 8153-8156
-
-
Wakui, H.1
Wright, A.P.2
Gustafsson, J.3
Zilliacus, J.4
-
27
-
-
0030995955
-
14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner
-
Craparo A, Freund R, Gustafson TA, (1997) 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J Biol Chem 272: 11663-11669.
-
(1997)
J Biol Chem
, vol.272
, pp. 11663-11669
-
-
Craparo, A.1
Freund, R.2
Gustafson, T.A.3
-
28
-
-
0029789477
-
Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function
-
Meller N, Liu YC, Collins TL, Bonnefoy-Berard N, Baier G, et al. (1996) Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function. Mol Cell Biol 16: 5782-5791.
-
(1996)
Mol Cell Biol
, vol.16
, pp. 5782-5791
-
-
Meller, N.1
Liu, Y.C.2
Collins, T.L.3
Bonnefoy-Berard, N.4
Baier, G.5
-
29
-
-
14744301343
-
JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage
-
Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y, (2005) JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol 7: 278-285.
-
(2005)
Nat Cell Biol
, vol.7
, pp. 278-285
-
-
Yoshida, K.1
Yamaguchi, T.2
Natsume, T.3
Kufe, D.4
Miki, Y.5
-
30
-
-
0030698062
-
14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction
-
Dubois T, Rommel C, Howell S, Steinhussen U, Soneji Y, et al. (1997) 14-3-3 is phosphorylated by casein kinase I on residue 233. Phosphorylation at this site in vivo regulates Raf/14-3-3 interaction. J Biol Chem 272: 28882-28888.
-
(1997)
J Biol Chem
, vol.272
, pp. 28882-28888
-
-
Dubois, T.1
Rommel, C.2
Howell, S.3
Steinhussen, U.4
Soneji, Y.5
-
31
-
-
0034661857
-
Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155
-
Lizcano JM, Morrice N, Cohen P, (2000) Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J 349: 547-557.
-
(2000)
Biochem J
, vol.349
, pp. 547-557
-
-
Lizcano, J.M.1
Morrice, N.2
Cohen, P.3
-
32
-
-
1642573162
-
PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin
-
Feng L, Yunoue S, Tokuo H, Ozawa T, Zhang D, et al. (2004) PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin. FEBS Lett 557: 275-282.
-
(2004)
FEBS Lett
, vol.557
, pp. 275-282
-
-
Feng, L.1
Yunoue, S.2
Tokuo, H.3
Ozawa, T.4
Zhang, D.5
-
33
-
-
34248212788
-
Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation
-
Palmer D, Jimmo SL, Raymond DR, Wilson LS, Carter RL, et al. (2007) Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation. J Biol Chem 282: 9411-9419.
-
(2007)
J Biol Chem
, vol.282
, pp. 9411-9419
-
-
Palmer, D.1
Jimmo, S.L.2
Raymond, D.R.3
Wilson, L.S.4
Carter, R.L.5
-
34
-
-
33645920993
-
14-3-3 protein signaling in development and growth factor responses
-
Thomas D, Guthridge M, Woodcock J, Lopez A, (2005) 14-3-3 protein signaling in development and growth factor responses. Curr Top Dev Biol 67: 285-303.
-
(2005)
Curr Top Dev Biol
, vol.67
, pp. 285-303
-
-
Thomas, D.1
Guthridge, M.2
Woodcock, J.3
Lopez, A.4
-
35
-
-
55749107651
-
RIM1alpha phosphorylation at serine-413 by protein kinase A is not required for presynaptic long-term plasticity or learning
-
Kaeser PS, Kwon HB, Blundell J, Chevaleyre V, Morishita W, et al. (2008) RIM1alpha phosphorylation at serine-413 by protein kinase A is not required for presynaptic long-term plasticity or learning. Proc Natl Acad Sci U S A 105: 14680-14685.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 14680-14685
-
-
Kaeser, P.S.1
Kwon, H.B.2
Blundell, J.3
Chevaleyre, V.4
Morishita, W.5
-
36
-
-
0141987893
-
Phosphorylation of RIM1alpha by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses
-
Lonart G, Schoch S, Kaeser PS, Larkin CJ, Sudhof TC, et al. (2003) Phosphorylation of RIM1alpha by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses. Cell 115: 49-60.
-
(2003)
Cell
, vol.115
, pp. 49-60
-
-
Lonart, G.1
Schoch, S.2
Kaeser, P.S.3
Larkin, C.J.4
Sudhof, T.C.5
-
37
-
-
0346461631
-
Mechanisms by which dopamine receptors may influence synaptic plasticity
-
Wolf ME, Mangiavacchi S, Sun X, (2003) Mechanisms by which dopamine receptors may influence synaptic plasticity. Ann N Y Acad Sci 1003: 241-249.
-
(2003)
Ann N Y Acad Sci
, vol.1003
, pp. 241-249
-
-
Wolf, M.E.1
Mangiavacchi, S.2
Sun, X.3
-
38
-
-
1342323630
-
DARPP-32: an integrator of neurotransmission
-
Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, et al. (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44: 269-296.
-
(2004)
Annu Rev Pharmacol Toxicol
, vol.44
, pp. 269-296
-
-
Svenningsson, P.1
Nishi, A.2
Fisone, G.3
Girault, J.A.4
Nairn, A.C.5
-
39
-
-
77957794336
-
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
-
Melrose HL, Dachsel JC, Behrouz B, Lincoln SJ, Yue M, et al. Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice. Neurobiol Dis 40: 503-517.
-
Neurobiol Dis
, vol.40
, pp. 503-517
-
-
Melrose, H.L.1
Dachsel, J.C.2
Behrouz, B.3
Lincoln, S.J.4
Yue, M.5
-
40
-
-
70149124508
-
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
-
Tong Y, Pisani A, Martella G, Karouani M, Yamaguchi H, et al. (2009) R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc Natl Acad Sci U S A 106: 14622-14627.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 14622-14627
-
-
Tong, Y.1
Pisani, A.2
Martella, G.3
Karouani, M.4
Yamaguchi, H.5
-
41
-
-
67649813448
-
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease
-
Li Y, Liu W, Oo TF, Wang L, Tang Y, et al. (2009) Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci 12: 826-828.
-
(2009)
Nat Neurosci
, vol.12
, pp. 826-828
-
-
Li, Y.1
Liu, W.2
Oo, T.F.3
Wang, L.4
Tang, Y.5
-
42
-
-
33748154216
-
Induction of autophagy in axonal dystrophy and degeneration
-
Wang QJ, Ding Y, Kohtz DS, Mizushima N, Cristea IM, et al. (2006) Induction of autophagy in axonal dystrophy and degeneration. J Neurosci 26: 8057-8068.
-
(2006)
J Neurosci
, vol.26
, pp. 8057-8068
-
-
Wang, Q.J.1
Ding, Y.2
Kohtz, D.S.3
Mizushima, N.4
Cristea, I.M.5
-
43
-
-
59149086584
-
Molecular characterization of propionyllysines in non-histone proteins
-
Cheng Z, Tang Y, Chen Y, Kim S, Liu H, et al. (2009) Molecular characterization of propionyllysines in non-histone proteins. Mol Cell Proteomics 8: 45-52.
-
(2009)
Mol Cell Proteomics
, vol.8
, pp. 45-52
-
-
Cheng, Z.1
Tang, Y.2
Chen, Y.3
Kim, S.4
Liu, H.5
-
44
-
-
29244448703
-
Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap
-
Olsen JV, de Godoy LM, Li G, Macek B, Mortensen P, et al. (2005) Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol Cell Proteomics 4: 2010-2021.
-
(2005)
Mol Cell Proteomics
, vol.4
, pp. 2010-2021
-
-
Olsen, J.V.1
de Godoy, L.M.2
Li, G.3
Macek, B.4
Mortensen, P.5
-
45
-
-
20844457100
-
Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra
-
Chen Y, Kwon SW, Kim SC, Zhao Y, (2005) Integrated approach for manual evaluation of peptides identified by searching protein sequence databases with tandem mass spectra. J Proteome Res 4: 998-1005.
-
(2005)
J Proteome Res
, vol.4
, pp. 998-1005
-
-
Chen, Y.1
Kwon, S.W.2
Kim, S.C.3
Zhao, Y.4
|